Vivance Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 85

Employees

  • Latest Deal Type
  • Series B1

  • Latest Deal Amount
  • $23.9M

  • Investors
  • 17

Vivance General Information

Description

Developer of ultraportable dialysis devices designed for chronic kidney disease management. The company's system uses sorbent technology which regenerates and reconstitutes used dialysis fluid into fresh fluid and provides the necessary clearances of the uremic toxins, enabling patients to reduce treatment burden through a more convenient dialysis experience.

Contact Information

Website
vivance.com
Formerly Known As
Awak
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3 Tuas Lane
  • Singapore, 638612
  • Singapore
+65 6785
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
LOHAS & Wellness, Digital Health, SaaS, TMT
Corporate Office
  • 3 Tuas Lane
  • Singapore, 638612
  • Singapore
+65 6785

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vivance Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B1) 13-Sep-2023 $23.9M Completed Generating Revenue
3. Later Stage VC (Series A1) 13-Dec-2019 Completed Generating Revenue
2. Later Stage VC (Series A) 03-May-2017 $8.72M $19.9M Completed Generating Revenue
1. Corporate 01-Dec-2016 $11.2M $11.2M Completed Generating Revenue
To view Vivance’s complete valuation and funding history, request access »

Vivance Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A1
Series A 2,323,363 $3.75 $3.75 1x $3.75 7.08%
To view Vivance’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Vivance Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of ultraportable dialysis devices designed for chronic kidney disease management. The company's system uses so
Diagnostic Equipment
Singapore, Singapore
85 As of 2024

Tokyo, Japan
 

Helsinki, Finland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vivance Competitors (6)

One of Vivance’s 6 competitors is PENTAX Medical, a Corporation company based in Tokyo, Japan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PENTAX Medical Corporation Tokyo, Japan
Kamu Venture Capital-Backed Helsinki, Finland
Baxter International Corporation Deerfield, IL
Quanta Dialysis Technologies Venture Capital-Backed Warwick, United Kingdom
ExThera Medical Venture Capital-Backed Martinez, CA
To view Vivance’s complete competitors history, request access »

Vivance Patents

  • 38

    Total Documents Applications and Grants

  • Total Patents Families

  • 15

    Granted

  • 22

    Pending

  • Expiring in next 12 mo

Vivance Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202306512-D0 Sterilization device for a dialysis apparatus Inactive 03-May-2023
AU-2023270908-A1 Long shelf-life sorbent cartridge Pending 19-May-2022
AU-2022399263-A1 Sorbent for dialysis and sorbent system for regenerative dialysis Pending 30-Nov-2021
CA-3239058-A1 Sorbent for dialysis and sorbent system for regenerative dialysis Pending 30-Nov-2021
EP-4440747-A2 Sorbent for dialysis and sorbent system for regenerative dialysis Pending 30-Nov-2021 B01J39/12
To view Vivance’s complete patent history, request access »

Vivance Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vivance Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eckuity Growth/Expansion Minority
Enterprise Singapore Corporation Minority
Fidem Investment Venture Capital Minority
Greenoaks Capital Partners Venture Capital Minority
GS Ventures (Korea) Corporate Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

Vivance Investments (1)

Vivance’s most recent deal was a Later Stage VC with Diality for . The deal was made on 31-Mar-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Diality 31-Mar-2022 Later Stage VC Therapeutic Devices
To view Vivance’s complete investments history, request access »

Ready to get started?

Request a free trial

Vivance FAQs

  • When was Vivance founded?

    Vivance was founded in 2007.

  • Where is Vivance headquartered?

    Vivance is headquartered in Singapore, Singapore.

  • What is the size of Vivance?

    Vivance has 85 total employees.

  • What industry is Vivance in?

    Vivance’s primary industry is Diagnostic Equipment.

  • Is Vivance a private or public company?

    Vivance is a Private company.

  • What is the current valuation of Vivance?

    The current valuation of Vivance is .

  • What is Vivance’s current revenue?

    The current revenue for Vivance is .

  • How much funding has Vivance raised over time?

    Vivance has raised $84.7M.

  • Who are Vivance’s investors?

    Eckuity, Enterprise Singapore, Fidem Investment, Greenoaks Capital Partners, and GS Ventures (Korea) are 5 of 17 investors who have invested in Vivance.

  • Who are Vivance’s competitors?

    PENTAX Medical, Kamu, Baxter International, Quanta Dialysis Technologies, and ExThera Medical are some of the 6 competitors of Vivance.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »